Cargando…

Solution NMR Studies of Mycobacterium tuberculosis Proteins for Antibiotic Target Discovery

Tuberculosis is an infectious disease caused by Mycobacterium tuberculosis, which triggers severe pulmonary diseases. Recently, multidrug/extensively drug-resistant tuberculosis strains have emerged and continue to threaten global health. Because of the development of drug-resistant tuberculosis, th...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kim, Do-Hee, Kang, Sung-Min, Lee, Bong-Jin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2017
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6151718/ https://www.ncbi.nlm.nih.gov/pubmed/28858250 http://dx.doi.org/10.3390/molecules22091447

Ejemplares similares

NMR Study on Small Proteins from Helicobacter pylori for Antibiotic Target Discovery: A Review
por: Kang, Su-Jin, et al.
Publicado: (2013)

Solution NMR Spectroscopy in Target-Based Drug Discovery
por: Li, Yan, et al.
Publicado: (2017)

Discovery of the first macrolide antibiotic binding protein in Mycobacterium tuberculosis: a new antibiotic resistance drug target
por: Zhang, Qingqing, et al.
Publicado: (2018)

Functional details of the Mycobacterium tuberculosis VapBC26 toxin-antitoxin system based on a structural study: insights into unique binding and antibiotic peptides
por: Kang, Sung-Min, et al.
Publicado: (2017)

The crystal structure of AcrR from Mycobacterium tuberculosis reveals a one‐component transcriptional regulation mechanism
por: Kang, Sung‐Min, et al.
Publicado: (2019)

Toxin-Activating Stapled Peptides Discovered by Structural Analysis Were Identified as New Therapeutic Candidates That Trigger Antibacterial Activity against Mycobacterium tuberculosis in the Mycobacterium smegmatis Model
por: Kang, Sung-Min, et al.
Publicado: (2021)

Applications of Solution NMR in Drug Discovery
por: Shi, Li, et al.
Publicado: (2021)

Application of Solution NMR to Structural Studies on α-Helical Integral Membrane Proteins
por: Sim, Dae-Won, et al.
Publicado: (2017)

A Practical Perspective on the Roles of Solution NMR Spectroscopy in Drug Discovery
por: Li, Qingxin, et al.
Publicado: (2020)

Failing upwards: Genetics-based strategies to improve antibiotic discovery and efficacy in Mycobacterium tuberculosis
por: Tomasi, Francesca G., et al.
Publicado: (2022)

Mean Platelet Volume in Mycobacterium tuberculosis Infection
por: Lee, Min Young, et al.
Publicado: (2016)

Wollamide Cyclic Hexapeptides Synergize with Established and New Tuberculosis Antibiotics in Targeting Mycobacterium tuberculosis
por: Rollo, Rachel F., et al.
Publicado: (2023)

Discovery of Novel Oral Protein Synthesis Inhibitors of Mycobacterium tuberculosis That Target Leucyl-tRNA Synthetase
por: Palencia, Andrés, et al.
Publicado: (2016)

Tools to develop antibiotic combinations that target drug tolerance in Mycobacterium tuberculosis
por: Greenstein, Talia, et al.
Publicado: (2023)

Predicting nitroimidazole antibiotic resistance mutations in Mycobacterium tuberculosis with protein engineering
por: Lee, Brendon M., et al.
Publicado: (2020)

Solution-state NMR structure and biophysical characterization of zinc-substituted rubredoxin B (Rv3250c) from Mycobacterium tuberculosis
por: Buchko, Garry W., et al.
Publicado: (2011)

Susceptibility of β-Lactam Antibiotics and Genetic Mutation of Drug-Resistant Mycobacterium tuberculosis Isolates in Korea
por: Park, Sanghee, et al.
Publicado: (2022)

NMR in target driven drug discovery: why not?
por: Keiffer, Sébastien, et al.
Publicado: (2020)

Cosolvent Sites-Based Discovery of Mycobacterium Tuberculosis Protein Kinase G Inhibitors
por: Burastero, Osvaldo, et al.
Publicado: (2022)

STAP Refinement of the NMR database: a database of 2405 refined solution NMR structures
por: Yang, Joshua SungWoo, et al.
Publicado: (2012)

Targeting of Mycobacterium tuberculosis Heparin-Binding Hemagglutinin to Mitochondria in Macrophages
por: Sohn, Hosung, et al.
Publicado: (2011)

A soft-computation hybrid method for search of the antibiotic-resistant gene in Mycobacterium tuberculosis for promising drug target identification and antimycobacterial lead discovery
por: Jaiswal, Neha, et al.
Publicado: (2023)

Targeting Energy Metabolism in Mycobacterium tuberculosis, a New Paradigm in Antimycobacterial Drug Discovery
por: Bald, Dirk, et al.
Publicado: (2017)

Genome-Wide Discovery of Small RNAs in Mycobacterium tuberculosis
por: Miotto, Paolo, et al.
Publicado: (2012)

Discovery of Novel Enhancers of Isoniazid Toxicity in Mycobacterium tuberculosis
por: Lentz, Fabian, et al.
Publicado: (2018)

Mycobacterium Tuberculosis in Spinal Tuberculosis
por: Moon, Myung-Sang, et al.
Publicado: (2017)

Strategies in anti-Mycobacterium tuberculosis drug discovery based on phenotypic screening
por: Grzelak, Edyta M., et al.
Publicado: (2019)

A Structural Approach into Drug Discovery Based on Autophagy
por: Kang, Sung-Min, et al.
Publicado: (2021)

Discovery of a unique Mycobacterium tuberculosis protein through proteomic analysis of urine from patients with active tuberculosis
por: Pollock, Nira, et al.
Publicado: (2018)

Development of NMR and thermal shift assays for the evaluation of Mycobacterium tuberculosis isocitrate lyase inhibitors
por: Bhusal, Ram Prasad, et al.
Publicado: (2017)

Optimal Combination of VNTR Typing for Discrimination of Isolated Mycobacterium tuberculosis in Korea
por: Lee, Jihye, et al.
Publicado: (2014)

Dual inhibition of the terminal oxidases eradicates antibiotic‐tolerant Mycobacterium tuberculosis
por: Lee, Bei Shi, et al.
Publicado: (2020)

Therapeutic Targeting of Protein Tyrosine Phosphatases from Mycobacterium tuberculosis
por: Ruddraraju, Kasi Viswanatharaju, et al.
Publicado: (2020)

Paramagnetic NMR in drug discovery
por: Softley, Charlotte A., et al.
Publicado: (2020)

Protein Linewidth and Solvent Dynamics in Frozen Solution NMR
por: Siemer, Ansgar B., et al.
Publicado: (2012)

(19)F-NMR reveals substrate specificity of CYP121A1 in Mycobacterium tuberculosis
por: Campomizzi, Christopher S., et al.
Publicado: (2021)

Applications of In-Cell NMR in Structural Biology and Drug Discovery
por: Kang, CongBao
Publicado: (2019)

A Potential Protein Adjuvant Derived from Mycobacterium tuberculosis Rv0652 Enhances Dendritic Cells-Based Tumor Immunotherapy
por: Lee, Seung Jun, et al.
Publicado: (2014)

Comparison of In-house PCR with Conventional Techniques and Cobas Amplicor M. tuberculosis™ Kit for Detection of Mycobacterium tuberculosis
por: Kim, Myeong-Hee, et al.
Publicado: (2008)

Transition bias influences the evolution of antibiotic resistance in Mycobacterium tuberculosis
por: Payne, Joshua L., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_7m18eo82obenkrimqnveucqap0